Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

COMFORTIS DIN 02332531

Status: Cancelled Post Market
Holder: ELANCO CANADA LIMITED
Molecule: SPINOSAD

Health Canada record

Active ingredient(s)SPINOSAD 1620 MG
Dosage formTablet (Chewable)
RouteOral
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date29-Dec-2009
Current status date30-Jul-2026
SourceHealth Canada DPD

Establishment licence of the holder

Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing SPINOSAD

DINProductCompanyFormStrengthStatus
02332493COMFORTISELANCO CANADA LIMITEDTablet (Chewable)SPINOSAD 140 MGCancelled Post Market
02332507COMFORTISELANCO CANADA LIMITEDTablet (Chewable)SPINOSAD 270 MGCancelled Post Market
02332515COMFORTISELANCO CANADA LIMITEDTablet (Chewable)SPINOSAD 560 MGCancelled Post Market
02332523COMFORTISELANCO CANADA LIMITEDTablet (Chewable)SPINOSAD 810 MGCancelled Post Market
02393115COMFORTISELANCO CANADA LIMITEDTablet (Chewable)SPINOSAD 90 MGCancelled Post Market
02375478TRIFEXISELANCO CANADA LIMITEDTablet (Chewable)SPINOSAD 270 MG; MILBEMYCIN OXIME 4.5 MGCancelled Post Market
02375486TRIFEXISELANCO CANADA LIMITEDTablet (Chewable)SPINOSAD 560 MG; MILBEMYCIN OXIME 9.3 MGCancelled Post Market
02375494TRIFEXISELANCO CANADA LIMITEDTablet (Chewable)SPINOSAD 810 MG; MILBEMYCIN OXIME 13.5 MGCancelled Post Market
02375524TRIFEXISELANCO CANADA LIMITEDTablet (Chewable)SPINOSAD 1620 MG; MILBEMYCIN OXIME 27 MGCancelled Post Market
02375451TRIFEXISELANCO CANADA LIMITEDTablet (Chewable)SPINOSAD 140 MG; MILBEMYCIN OXIME 2.3 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
206802018-03-28New Drug Submission (NDS)MERGER - BUYOUT
105332009-08-24New Drug Submission (NDS)

International API supply for SPINOSAD

5 active FDA Drug Master Files.

Request a quote for COMFORTIS

How to read a Canadian DIN record